Cited 25 time in
Cited 26 time in
SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle
- SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle
- Koo, Young Do; Choi, Jin Woo; Kim, Myungjin; Chae, Sehyun; Ahn, Byung Yong; Kim, Min; Oh, Byung Chul; Hwang, Dae Hee; Seol, Jae Hong; Kim, Young-Bum; Park, Young Joo; Chung, Sung Soo; Park, Kyong Soo
- DGIST Authors
- Hwang, Dae Hee
- Issue Date
- Diabetes, 64(7), 2420-2431
- Article Type
- ACTIVATED RECEPTOR-GAMMA; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; UNCOUPLING PROTEIN-3; PROSTATE-CANCER; BETA-OXIDATION; CELLS; SUMOYLATION; DEGRADATION; TRANSCRIPTION
- Small ubiquitin-like modifier (SUMO)-specific proteases (SENPs) that reverse protein modification by SUMO are involved in the control of numerous cellular processes, including transcription, cell division, and cancer development. However, the physiological function of SENPs in energy metabolism remains unclear. Here, we investigated the role of SENP2 in fatty acid metabolism in C2C12 myotubes and in vivo. In C2C12 myotubes, treatment with saturated fatty acids, like palmitate, led to nuclear factor-kB- mediated increase in the expression of SENP2. This increase promoted the recruitment of peroxisome proliferator- activated receptor (PPAR)d and PPARg, through desumoylation of PPARs, to the promoters of the genes involved in fatty acid oxidation (FAO), such as carnitinepalmitoyl transferase-1 (CPT1b) and long-chain acyl-CoA synthetase 1 (ACSL1). In addition, SENP2 overexpression substantially increased FAO in C2C12 myotubes. Consistent with the cell culture system, muscle-specific SENP2 overexpression led to a marked increase in the mRNA levels of CPT1b and ACSL1 and thereby in FAO in the skeletal muscle, which ultimately alleviated high-fat diet- induced obesity and insulin resistance. Collectively, these data identify SENP2 as an important regulator of fatty acid metabolism in skeletal muscle and further implicate that muscle SENP2 could be a novel therapeutic target for the treatment of obesity-linked metabolic disorders. © 2015 by the American Diabetes Association.
- American Diabetes Association
There are no files associated with this item.
- Department of New BiologySystems Biology and Medicine Lab1. Journal Articles
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.